Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review

(2016) Jonathan Shuter   Therapeutics and Clinical Risk Management

Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans

(2009) Xiaoqiang Xiang et al.   Pharmacogenetics and Genomics

Cellular Accumulation of Cholyl-Glycylamido-Fluorescein in Sandwich-Cultured Rat Hepatocytes: Kinetic Characterization, Transport Mechanisms, and Effect of Human Immunodeficiency Virus Protease Inhibitors

(2008) Z.-w. Ye et al.   DRUG METABOLISM AND DISPOSITION

Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories

(2008) Rose Hayeshi et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3

(2008) Chunshan Gui et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Drug/Drug Interaction Between Lopinavir/Ritonavir and Rosuvastatin in Healthy Volunteers

(2008) Jennifer J Kiser et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Role of transport proteins in drug discovery and development: a pharmaceutical perspective

(2008) A. Ayrton et al.   XENOBIOTICA

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family

(2008) B. Hagenbuch et al.   XENOBIOTICA

Application and limitation of inhibitors in drug–transporter interactions studies

(2007) Qing Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS